Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Jul 25 - Jul 30
without the PPARγ mediated adverse effects on body weight and heart weight
LTD4 induces bronchoconstriction (ED50 = 0
OSI-420 (CP-473420) is an active metabolite of erlotinib which is an orally active EGFR tyrosin kinase inhibitor with IC50 of 2 and 20 nM for the inhibition of human EGFR and EGFR autophosphorylation in tumor cells
PubMed PMID: 9863222
InChiKey: AIFRHYZBTHREPW-UHFFFAOYSA-N
SH-4-54 Catalog No.:M19732-C without the PPARγ mediated adverseSH 4 54 is a STAT inhibitor that binds to STAT3 and STAT5 with KDs of 300, 464 nM, respectively. Product information CAS Number: 1456632 40 8 Molecular Weight: 610. 59 Formula: C29H27F5N2O5S Chemical Name: 4 {N [(4 cyclohexylphenyl)methyl] 2 (N methyl2,3,4,5,6 pentafluorobenzenesulfonamido)acetamido}benzoic acid Smiles: CN(CC(=O)N(CC1C=CC(=CC=1)C1CCCCC1)C1C=CC(=CC=1)C(O)=O)S(=O)(=O)C1C(F)=C(F)C(F)=C(F)C=1F InChiKey: VFPYGNNOSJWBHF UHFFFAOYSA N InChi:
US$ 1075.00
US$ 347.50
US$ 100.00